Group 1 - The core viewpoint of the article emphasizes the transformation of China's medical technology from isolated breakthroughs to a structured and systematic capability, driven by policies and collaborative ecosystems [2][11]. - The Beijing medical and health industry has surpassed 1.06 trillion yuan, with a leading number of innovative device registrations, indicating a robust growth trajectory [1]. - The 2025 Global MedTech Conference highlighted key areas such as artificial intelligence and brain-machine interfaces, showcasing the focus on technology empowerment and practical application [2]. Group 2 - The importance of cross-disciplinary collaboration in medical technology implementation is underscored, with a call for integration between academic institutions, clinical resources, and industry [5]. - The "smart review" mechanism in Beijing aims to enhance registration efficiency for medical devices, emphasizing a design loop centered on clinical value [12]. - The conference presented the 2025 Global MedTech Top 100 list, featuring 12 Chinese companies, reflecting the growing international presence of Chinese medical technology firms [9]. Group 3 - The article discusses various innovative medical technologies and their applications, such as AI-assisted clinical research and the development of a multi-modal data platform for kidney disease [27]. - Companies are increasingly focusing on the integration of AI in medical devices, with examples of advancements in ultrasound technology and the development of AI pathology diagnostic systems [39][44]. - The narrative indicates a shift in the medical technology sector towards achieving practical outcomes and operational efficiency, moving from theoretical capabilities to real-world applications [54].